Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.25 - $11.7 $2,568 - $120,205
10,274 Added 24.79%
51,716 $11,000
Q2 2022

Aug 15, 2022

BUY
$0.3 - $1.31 $12,432 - $54,289
41,442 New
41,442 $12,000
Q2 2021

Aug 16, 2021

SELL
$5.06 - $8.15 $867,906 - $1.4 Million
-171,523 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$6.24 - $9.58 $1.85 Million - $2.84 Million
-296,379 Reduced 63.34%
171,523 $1.16 Million
Q4 2020

Feb 16, 2021

BUY
$6.28 - $8.79 $2.94 Million - $4.11 Million
467,902 New
467,902 $3.17 Million
Q3 2020

Nov 16, 2020

SELL
$7.5 - $11.11 $1.27 Million - $1.88 Million
-168,815 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$8.33 - $13.79 $1.21 Million - $2.01 Million
145,615 Added 627.65%
168,815 $1.77 Million
Q1 2020

May 15, 2020

BUY
$3.83 - $8.79 $88,856 - $203,927
23,200 New
23,200 $204,000
Q1 2019

May 15, 2019

SELL
$5.19 - $8.97 $300,376 - $519,147
-57,876 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$4.29 - $9.94 $201,617 - $467,150
46,997 Added 432.0%
57,876 $283,000
Q3 2018

Nov 14, 2018

BUY
$9.54 - $13.87 $103,785 - $150,891
10,879 New
10,879 $107,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0

About Kala Pharmaceuticals, Inc.


  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $8.67M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.